Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Vincenzi

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2007
Occasional FDG PET recognition of in situ breast cancerB Vincenzi, A Calvieri, D Santini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2009
Potential role of everolimus in inducing cholestasisF Pantano, D Santini, F Guida, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2013
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancerD Santini, B Vincenzi, F Pantano, et al.
The British Journal of Surgery|August 29, 2003
Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients (Br J Surg 2003; 90: 547-548)B Vincenzi, D Santini, G Avvisati, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 9, 2007
Docetaxel induced pericardial effusionB Vincenzi, D Santini, A M Frezza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2006
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patientsD Santini, V Virzí, B Vincenzi, et al.
Allergy|February 7, 2004
Anaphylaxis to dexrazoxane (ICRF-187) following three previous uncomplicated infusionsV Leoni, D Santini, B Vincenzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2021
Novel drugs, familiar interactions: ciprofloxacin may increase exposure to the RET inhibitor pralsetinibF Citarella, M Russano, A Galletti, et al.
Journal of Veterinary Internal Medicine|March 9, 2011
Evaluation of Cisplatin as an electrochemotherapy agent for the treatment of incompletely excised mast cell tumors in dogsE P Spugnini, B Vincenzi, G Citro, et al.
La Clinica Terapeutica|July 1, 2011
New perspectives: role of Sunitinib in breast cancerM E Fratto, M Imperatori, B Vincenzi, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2007
Occasional FDG PET recognition of in situ breast cancerB Vincenzi, A Calvieri, D Santini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2009
Potential role of everolimus in inducing cholestasisF Pantano, D Santini, F Guida, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2013
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancerD Santini, B Vincenzi, F Pantano, et al.
The British Journal of Surgery|August 29, 2003
Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients (Br J Surg 2003; 90: 547-548)B Vincenzi, D Santini, G Avvisati, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 9, 2007
Docetaxel induced pericardial effusionB Vincenzi, D Santini, A M Frezza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2006
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patientsD Santini, V Virzí, B Vincenzi, et al.
Allergy|February 7, 2004
Anaphylaxis to dexrazoxane (ICRF-187) following three previous uncomplicated infusionsV Leoni, D Santini, B Vincenzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2021
Novel drugs, familiar interactions: ciprofloxacin may increase exposure to the RET inhibitor pralsetinibF Citarella, M Russano, A Galletti, et al.
Journal of Veterinary Internal Medicine|March 9, 2011
Evaluation of Cisplatin as an electrochemotherapy agent for the treatment of incompletely excised mast cell tumors in dogsE P Spugnini, B Vincenzi, G Citro, et al.
La Clinica Terapeutica|July 1, 2011
New perspectives: role of Sunitinib in breast cancerM E Fratto, M Imperatori, B Vincenzi, et al.
Pageof 12